Analytical evaluation of a commercial in-house homologous recombination deficiency (HRD) assay for patients with epithelial ovarian cancers and its concordance with a reference standard. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback